SEC penalises Sanofi for payments to government and private sector officials
Paris-based pharmaceutical company Sanofi has agreed to pay over $25 million to resolve FCPA charges brought by the SEC concerning conduct in Kazakhstan and the Middle East.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10